article thumbnail

Osimertinib Resistance and EGFR Mutations in NSCLC Treatment

Bioengineer

In patients with T790M mutant NSCLC receiving osimertinib, 63% experienced loss of T790M at progression, commonly linked to histological transdifferentiation, KRAS mutations, or gene fusions. The presence of the T790M mutation during first or second-generation EGFR-TKI treatments is observed in 50-60% of patients. months vs. 15.2

Genome 119
article thumbnail

Discover how iPSC derived cells can support drug and gene therapy development

Drug Discovery World

DDW recently hosted a webinar ‘Discover how iPSC derived cells can be used to support the development of drug and gene therapies’, supported by DefiniGEN. In addition, stable cell lines derived from cancers represent a single and karyotypically abnormal genotype.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Register now to discover how iPSC derived cells support gene therapy development

Drug Discovery World

Primary hepatocytes represent the gold standard in vitro cell model for functionality, however, when isolated from liver tissue, primary cells maintain expression of key proteins for only a short period. In addition, stable cell lines derived from cancers represent a single and karyotypically abnormal genotype.

article thumbnail

Using iPSC derived cells for the development of drug and gene therapies

Drug Discovery World

Primary hepatocytes represent the gold standard in vitro cell model for functionality, however, when isolated from liver tissue, primary cells maintain expression of key proteins for only a short period. In addition, stable cell lines derived from cancers represent a single and karyotypically abnormal genotype.

article thumbnail

Global Roundup: Overland Pharma Launches in China to Provide Access to Breakthrough Therapies

The Pharma Data

The Chinese biopharmaceutical industry is growing in leaps and bounds, but there is still a huge unmet need when it comes to getting patients access to the breakthrough therapeutic modalities and platforms like RNAi, cell and gene therapy and others. A solution could be at hand with Overland Pharmaceuticals.

In-Vivo 52
article thumbnail

Discover how iPSC derived cells can be used to support the development of drug and gene therapies

Drug Discovery World

Primary hepatocytes represent the gold standard in vitro cell model for functionality. Also, stable cell lines derived from cancers represent a single and karyotypically abnormal genotype. However, when isolated from liver tissue, primary cells maintain expression of key proteins for only a short period.

article thumbnail

How can iPSC derived cells can be used to support drug development?

Drug Discovery World

Primary hepatocytes represent the gold standard in vitro cell model for functionality, however, when isolated from liver tissue, primary cells maintain expression of key proteins for only a short period. In addition, stable cell lines derived from cancers represent a single and karyotypically abnormal genotype.